drugset / Trial / NCT07295717
A Study to Evaluate ALN-4285 in Adult Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to: * evaluate the safety and tolerability of single ascending doses of ALN-4285 in healthy volunteers * characterize the single-dose pharmacokinetics (PK) of ALN-4285
Timeline
- Start
- 2025-12-12
- Primary completion
- 2026-12-29
- Completion
- 2027-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALN-4285 | Unknown | — | Subcutaneous |
Indications
No indication recorded.